Breaking News Instant updates and real-time market news.

GDDY

GoDaddy

$64.91

-0.99 (-1.50%)

, WIX

Wix.com

$116.34

-0.41 (-0.35%)

11:25
10/01/19
10/01
11:25
10/01/19
11:25

Verisign data 'not good news' for GoDaddy, Wix.com, says JPMorgan

JPMorgan analyst Sterling Auty lowered net domain name additions for VeriSign (VRSN) to 1.27M from 1.62M based on data from its website, and noted this was the "first noticeable shortfall in quite some time." He said that website naming and building are cyclical in nature and added that this shortfall could be "the first step in a trend" and will be looking for further evidence and data to see if this is a one-off or a concern for companies like GoDaddy (GDDY) and Wix.com (WIX). Auty maintained a Neutral rating on both GoDaddy and Wix.com.

GDDY

GoDaddy

$64.91

-0.99 (-1.50%)

WIX

Wix.com

$116.34

-0.41 (-0.35%)

VRSN

VeriSign

$186.36

-2.27 (-1.20%)

  • 18

    Nov

GDDY GoDaddy
$64.91

-0.99 (-1.50%)

02/21/19
PIPR
02/21/19
NO CHANGE
Target $97
PIPR
Overweight
GoDaddy price target raised to $97 from $91 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for GoDaddy to $97 saying the company's Q4 results were "uneventful in a good way." GoDaddy remains on track for solid continued growth and its valuation is relatively attractive, Olson tells investors in a post-earnings research note. The analyst maintains an Overweight rating on the shares.
02/21/19
JEFF
02/21/19
NO CHANGE
Target $90
JEFF
Buy
GoDaddy remains a top-pick after 'on target' quarter at Jefferies
In a post-earnings research note titled "Consistent Like Curry's 3-Pointers," Jefferies analyst Brent Thill says GoDaddy's Q4 results and fiscal 2019 guidance "were on target." The stock can work in 2019 as the company again delivers 18%-20% unlevered free cash flow growth, driven by low double-digit revenue growth, Thill writes. GoDaddy remains one of his firm's top mid-cap picks with a Buy rating and $90 price target.
02/13/19
PIPR
02/13/19
NO CHANGE
PIPR
VeriSign results may signal little booking growth for GoDaddy, say Piper Jaffray
Piper Jaffray analyst Michael Olson maintained an Overweight rating and $91 price target on GoDaddy (GDDY), but lowered this Q4 booking estimates for the company based on Verisign's (VRSN) earnings report, which showed a slight top-line miss and lower sequential net adds, leading the analyst to believe there is minimal room for quarter-over-quarter bookings growth for GoDaddy in Q4. Olson lowered his Q4 bookings est to $740M from $744M, and his revenue estimtae to $692M from $695M, but left his EPS estimate of 19c unchanged. Olson believes, however, that "continued efforts on GoDaddy's website builder and eCommerce initiatives are closing the gap with builder rivals, such as Wix."
02/21/19
JPMS
02/21/19
NO CHANGE
Target $83
JPMS
Neutral
GoDaddy price target raised to $83 from $75 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for GoDaddy to $83 saying the company's Q4 results and 2019 outlook should be well received by investors as there were concerns about currency's impact on the outlook going into the print. The company is on track to deliver another year of 18% to 20% free cash flow growth in 2019, Auty tells investors in a research note. He keeps a Neutral rating on GoDaddy.
WIX Wix.com
$116.34

-0.41 (-0.35%)

07/25/19
RBCM
07/25/19
NO CHANGE
Target $166
RBCM
Outperform
Wix.com price target raised to $166 from $150 at RBC Capital
RBC Capital analyst Zachary Schwartzman raised his price target on Wix.com to $166 and kept his Outperform rating after its "mixed" quarter, saying that while net premium subscriptions growth was "a tad below" expectation, collection and free cash flows beat consensus and monetization showed improvement. The analyst says the company's fundamental trends have remained "consistent."
07/25/19
WEDB
07/25/19
NO CHANGE
Target $180
WEDB
Outperform
Wix.com price target raised to $180 from $152 at Wedbush
Wedbush analyst Ygal Arounian raised his price target for Wix.com to $180 from $152 and reiterated an Outperform rating on the shares saying that while he continues to see the quarter as "strong but not stellar," management tone on the conference call was positive and ultimately giving investors enough confidence that the company will come out of this transition year in a strong position with growth steadily improving through the second half of the year and into 2020. Arounian says Wix.com remains on his firm's Best Ideas List.
07/25/19
RHCO
07/25/19
NO CHANGE
Target $168
RHCO
Buy
Wix.com price target raised to $168 from $154 at SunTrust
SunTrust analyst Naved Khan raised his price target on Wix.com to $168 and kept his Buy rating after its Q2 earnings beat and raised FY19 guidance, saying that in addition to the DIY market, the company is also capturing more higher-value customers. The analyst also notes the company's higher first-half cohort collections despite the lower adds, stating that its ability to increase prices is supported by its "leading edge" product suite.
07/25/19
DBAB
07/25/19
NO CHANGE
Target $172
DBAB
Buy
Wix.com price target raised to $172 from $135 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Wix.com to $172 from $135 saying the company reported "solid" Q2 results and guidance. He keeps a Buy rating on Wix.com shares.
VRSN VeriSign
$186.36

-2.27 (-1.20%)

11/02/18
BARD
11/02/18
UPGRADE
Target $170
BARD
Outperform
VeriSign upgraded to Outperform after cooperative agreement amendment at Baird
As reported previously, Baird analyst Rob Oliver upgraded VeriSign to Outperform from Neutral following a disclosure that detailed an amendment to its cooperative agreement that grants the company the right to pursue up to 7% price increases in the last four years of its six year contract. This news removed legislative uncertainty and provides visibility going forward, said Oliver, who raised his price target to $170 from $160 on VeriSign shares.
12/18/18
RBCM
12/18/18
NO CHANGE
Target $34
RBCM
Outperform
AMD addition to Nasdaq-100 a 'small near-term positive', says RBC Capital
RBC Capital analyst Mitch Steves notes the addition of AMD (AMD) to the Nasdaq-100 index announced late on Friday, which also contained the inclusion of lululemon (LULU), NetApp (NTAP), United Continental Holdings (UAL), VeriSign (VRSN) and Willis Towers Watson (WLTW) and the subtraction of Express Scripts Holding (ESRX), Hologic (HOLX), Qurate Retail (QRTEA), Shire (SHPG), Seagate Technology (STX) and Vodafone Plc (VOD). The analyst believes that the change - which will become effective before the market open on December 24th - could act as a "small near-term positive" for AMD shares, even though it does not change its fundamentals. Longer term, the analyst keeps his Outperform rating and $34 price target on AMD, but warns that the company is faced with a crypto currency downdraft in the Gaming segment and that he is also cautious on the hyperscale spending trends next year which he estimates in the low single digits. Steves adds that the notable investor debate is also taking place around the AMD server average selling prices, which he sees coming in around $5,400 - the higher end of the more bullish forecasts of $5K-$6K vs. the bears' estimate around $4K.
11/02/18
11/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Emergent BioSolutions (EBS) upgraded to Buy from Neutral at Goldman Sachs with analyst Dana Flanders saying he sees an "underappreciated opportunity" for Emergent to expand into other verticals, highlighted by Narcan nasal spray. 2. Michael Kors (KORS) upgraded to Buy from Neutral at UBS and to Overweight from Neutral at Piper Jaffray. 3. Parker-Hannifin (PH) upgraded to Outperform from Market Perform at Wells Fargo with analyst Andrew Casey sayoing the recent selloff has created an opportunity "to get back on board the PH stock train." 4. Ingredion (INGR) upgraded to Neutral from Sell at Citi with analyst David Driscoll saying the worst is now likely behind the company's North American operations, which should resume growth in 2019 "when many of the transitory 2018 issues will be in the rear view mirror." 5. VeriSign (VRSN) upgraded to Neutral from Underweight at JPMorgan and to Outperform from Neutral at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FLXN

Flexion

$13.37

0.125 (0.94%)

08:47
10/14/19
10/14
08:47
10/14/19
08:47
Recommendations
Flexion analyst commentary  »

Benchmark still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

, USAT

USA Technologies

$0.00

(0.00%)

08:45
10/14/19
10/14
08:45
10/14/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

USAT

USA Technologies

$0.00

(0.00%)

BYND

Beyond Meat

$131.40

-4.6 (-3.38%)

CGC

Canopy Growth

$19.42

-1.005 (-4.92%)

CHK

Chesapeake

$1.38

0.09 (6.98%)

PZZA

Papa John's

$53.16

0.32 (0.61%)

NVAX

Novavax

$4.57

0.11 (2.47%)

DXJ

WisdomTree Japan Hedged Equity Fund

$51.12

1.1 (2.20%)

PTON

Peloton

$22.40

-0.755 (-3.26%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Recommendations
Netflix analyst commentary  »

RBC Capital sees Q3 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

AKTX

Akari Therapeutics

$1.81

-0.03 (-1.63%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Hot Stocks
Akari Therapeutics announces new data from ongoing Phase I/II AKC trial »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:41
10/14/19
10/14
08:41
10/14/19
08:41
Hot Stocks
Parsley Energy sees Jagged Peak Energy deal immediately accretive on key metrics »

Key Transaction…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

08:40
10/14/19
10/14
08:40
10/14/19
08:40
Initiation
Envista initiated  »

Envista initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVST

Envista

$27.87

-1.2 (-4.13%)

, DHR

Danaher

$138.78

0.1 (0.07%)

08:38
10/14/19
10/14
08:38
10/14/19
08:38
Initiation
Envista, Danaher initiated  »

Envista initiated with an…

NVST

Envista

$27.87

-1.2 (-4.13%)

DHR

Danaher

$138.78

0.1 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

KALV

KalVista

$11.00

0.27 (2.52%)

, RGNX

Regenxbio

$39.53

0.65 (1.67%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Recommendations
KalVista, Regenxbio, Kala Pharmaceuticals, Kodiak Sciences, Regeneron, Aerie Pharmaceuticals, Applied Genetic, Aldeyra, Adverum Biotechnologies, Clearside Biomedical, Ocugen analyst commentary  »

Ophthalmic therapies…

KALV

KalVista

$11.00

0.27 (2.52%)

RGNX

Regenxbio

$39.53

0.65 (1.67%)

KALA

Kala Pharmaceuticals

$3.45

-0.15 (-4.17%)

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

REGN

Regeneron

$301.02

2.56 (0.86%)

AERI

Aerie Pharmaceuticals

$20.15

2.45 (13.84%)

AGTC

Applied Genetic

$3.10

-0.08 (-2.52%)

ALDX

Aldeyra

$5.16

-0.09 (-1.71%)

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

CLSD

Clearside Biomedical

$0.76

0.0326 (4.47%)

OCGN

Ocugen

$1.51

-0.07 (-4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 24

    Oct

  • 05

    Nov

  • 06

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Hot Stocks
Parsley Energy, Jagged Peak Energy boards 'unanimously' approve merger »

The boards of directors…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HPE

HP Enterprise

$14.35

0.24 (1.70%)

08:36
10/14/19
10/14
08:36
10/14/19
08:36
Upgrade
HP Enterprise rating change  »

HP Enterprise upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

, BABA

Alibaba

$172.97

6.925 (4.17%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Genius Brands, Alibaba partner to co-produce animated children's series »

Genius Brands…

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

BABA

Alibaba

$172.97

6.925 (4.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Parsley Energy sees FY20 CapEx $1.6B-$1.9B »

Parsley (PE) remains…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CUB

Cubic

$68.86

0.58 (0.85%)

, SAIC

SAIC

$84.56

1.05 (1.26%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Cubic appoints Hilary Hageman as general counsel »

Cubic (CUB) announced the…

CUB

Cubic

$68.86

0.58 (0.85%)

SAIC

SAIC

$84.56

1.05 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

BLPH

Bellerophon

$0.45

-0.0104 (-2.26%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Bellerophon to present new data from Cohort 1 of Phase 2/3 study of INOpulse »

lpBellerophon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Parsley Energy sees Q3 net oil production 91.2-91.7 MBo per day »

For the third quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AXAS

Abraxas Petroleum

$0.37

0.0069 (1.89%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Earnings
Abraxas Petroleum broadens engagement with Petrie Partners »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:32
10/14/19
10/14
08:32
10/14/19
08:32
Hot Stocks
Parsley Energy to acquire Jagged Peak Energy in $2.27B all-stock transaction »

Parsley Energy (PE) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

RARE

Ultragenyx

$42.77

1.08 (2.59%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Hot Stocks
Ultragenyx announces FDA acceptance of NDA for UX007 »

Ultragenyx Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$260.46

8.86 (3.52%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Recommendations
ASML analyst commentary  »

ASML price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:30
10/14/19
10/14
08:30
10/14/19
08:30
Hot Stocks
Breaking Hot Stocks news story on Parsley Energy, Jagged Peak Energy »

Parsley Energy acquires…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DRYS

DryShips

$5.25

(0.00%)

, NCI

Navigant Consulting

$28.00

(0.00%)

08:30
10/14/19
10/14
08:30
10/14/19
08:30
Options
Four option delistings on October 14th »

Option delistings…

DRYS

DryShips

$5.25

(0.00%)

NCI

Navigant Consulting

$28.00

(0.00%)

TYPE

Monotype Imaging

$19.85

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$42.40

0.15 (0.36%)

08:29
10/14/19
10/14
08:29
10/14/19
08:29
Initiation
Omega Healthcare initiated  »

Omega Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:25
10/14/19
10/14
08:25
10/14/19
08:25
Recommendations
Netflix analyst commentary  »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
10/14/19
10/14
08:24
10/14/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
10/14/19
10/14
08:24
10/14/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.